SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, estimate the tumor’s proliferative capacity and measure prognostically useful gene signatures in a single test and from a blood sample,” said Dr.

#Myeloma Paper of the Day: SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating MM/precursor tumor cells & generate model where tumor burden, proliferation, cytogenetics & circulatory capacity signature influence CTC: pubmed.ncbi.nlm.nih.gov/40781193/. #mmsm

Myeloma Paper of the Day, August 10th, Suggested by Robert Orlowski (Robert Z. Orlowski) Irene Ghobrial Nature Cancer oncodaily.com/science/myelom… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #MM #Myeloma #SWIFTseq CancerWorld

Through cutting-edge scRNAseq, Ghobrial Lab confirms the potential of #CTCs for minimally invasive genomic profiling in #mmsm! 💪🩸 nature.com/articles/s4301…

Drs. Irene Ghobrial, Romanos SP, and Elizabeth Lightbody at Dana-Farber have developed a blood test that could transform the diagnosis and monitoring of #MultipleMyeloma and its precursor conditions. Press release: bit.ly/4mEUUXB Nature Cancer: go.nature.com/4mG8UAi

🚨 New article alert! 🚨 Check out our last release by Irene Ghobrial and colleagues on "SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors" Dana-Farber 👉nature.com/articles/s4301…

Excited to share our new paper, out today on Nature Genetics where we use 421 #WGS to reconstruct the evolutionary history of multiple myeloma #mmsm (🔥🔥). Great collaboration with Heidelberg Myeloma Sylvester Comprehensive Cancer Center Mayo Clinic Memorial Sloan Kettering Cancer Center MSK Department of Medicine ⁦.

SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma & its precursors [Aug 8, 2025] Lightbody, Romanos SP et al. Irene Ghobrial - Ghobrial Lab Nature Cancer nature.com/articles/s4301… #mmsm #LiquidBiopsy #cactc

Hi friends, it's #Myeloma Monday! Here are Top Posts of the Week 🧵 1/ Tarek Mouhieddine, MD on joining the faculty at Dana Farber: x.com/tarekmd91/stat…

As we promised, finally the paper is out! 👉Elevated #CTCs reflect high proliferation and genomic complexity in #mmsm onlinelibrary.wiley.com/doi/10.1002/he…

🎉Congrats to portfolio company @PredictaBiosciences on the close of a $23.4 million #SeriesA and appointment of CEO Brian McKernan. The funding will support development of #diagnostics for blood cancers and autoimmune diseases. 📢 Announcement: businesswire.com/news/home/2025… #PartnerNews